Intended for U.S. scientific audiences only.

BMS at #EULAR 2019

Investigating personalized approaches and addressing unmet immune-mediated disease patient needs.


A

t the European Congress of Rheumatology 2019 (EULAR 2019 – June 12-15 in Madrid), we’re presenting 27 Bristol-Myers Squibb-sponsored abstracts, underscoring our commitment to informing better, more personalized approaches in immune-mediated diseases where treatment options are limited or improvements are needed. The presented data include clinical and real-world results that support our focuses on furthering precision medicine in rheumatoid arthritis and addressing patient unmet needs in juvenile idiopathic arthritis. Findings on new modes of action being explored as part of our early Immunoscience program will also be shared.


Resources

Advancing Personalized Medicine Research in RA and Beyond: A Q&A with Dr. Sean E. Connolly

Advancing Personalized Medicine Research in RA and Beyond: A Q&A with Dr. Sean E. Connolly

Our Dr. Sean E. Connolly explains our personalized medicine research approach and shares a video on the potential role of biomarkers.
Spotlight: Juvenile Idiopathic Arthritis

Spotlight: Juvenile Idiopathic Arthritis

Get the facts on the most common chronic rheumatic disease affecting children and teens.
Spotlight: Rheumatoid Arthritis

Spotlight: Rheumatoid Arthritis 

Learn more about this destructive immune-mediated disease and how it can behave differently in different people.

Web of Discovery

Explore immune system interconnectivity.
Personalized Disease Management Approaches

Immune-Mediated Disease Research Perspectives 

Hear our leaders and scientists explain what the latest research means for patients and families.
Disease State Infographics

Disease State Infographics

Learn about the immune-mediated diseases we’re researching.